RxSight, Inc. (RXST)

NASDAQ: RXST · Real-Time Price · USD
8.05
-0.41 (-4.85%)
Jul 11, 2025, 11:25 AM - Market open
-4.85%
Market Cap 327.13M
Revenue (ttm) 148.31M
Net Income (ttm) -26.55M
Shares Out 40.64M
EPS (ttm) -0.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 536,768
Open 8.33
Previous Close 8.46
Day's Range 8.02 - 8.50
52-Week Range 6.32 - 58.23
Beta 1.21
Analysts Hold
Price Target 19.40 (+140.99%)
Earnings Date Aug 7, 2025

About RXST

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 30, 2021
Employees 498
Stock Exchange NASDAQ
Ticker Symbol RXST
Full Company Profile

Financial Performance

In 2024, RxSight's revenue was $139.93 million, an increase of 57.09% compared to the previous year's $89.08 million. Losses were -$27.46 million, -43.52% less than in 2023.

Financial Statements

Analyst Summary

According to 11 analysts, the average rating for RXST stock is "Hold." The 12-month stock price target is $19.4, which is an increase of 140.99% from the latest price.

Price Target
$19.4
(140.99% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether RxSight, Inc. (NASDAQ: RXST), or any of its executive officers, violated federal ...

1 hour ago - GlobeNewsWire

Crude Oil Moves Higher; RxSight Shares Plunge

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.

1 day ago - Benzinga

Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday.

Other symbols: AEHREVTL
2 days ago - Benzinga

RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance

ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

2 days ago - GlobeNewsWire

RxSight: Valuation Blowout Creates Opportunity

RxSight is a promising growth stock in the medical device sector, focusing on innovative cataract treatments with a large addressable market. Despite a recent decline, RxSight's high margins and scala...

4 weeks ago - Seeking Alpha

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

7 weeks ago - GlobeNewsWire

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: PRTASRPT
2 months ago - Benzinga

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Oliver Moravcevic - Vice President, Investor Relations Ron Kurtz - President & Chief Executive...

2 months ago - Seeking Alpha

RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin...

2 months ago - GlobeNewsWire

​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)

RxSight posted a sequential revenue decline, revealing cracks in momentum despite earlier signs of profitability. Revised 2025 outlook and lack of expected profitability suggest earlier optimism was p...

3 months ago - Seeking Alpha

RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)

RxSight, Inc. (NASDAQ:RXST) Q1 2025 Preliminary Results Conference Call April 3, 2025 8:00 AM ET Company Participants Oliver Moravcevic - VP, IR Dr. Ron Kurtz - Director, Co-President and CEO Shelley...

3 months ago - Seeking Alpha

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

3 months ago - GlobeNewsWire

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin...

3 months ago - GlobeNewsWire

RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Oliver Moravcevic - VP, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference...

4 months ago - Seeking Alpha

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

4 months ago - GlobeNewsWire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

6 months ago - GlobeNewsWire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

6 months ago - GlobeNewsWire

RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye

RxSight's light adjustable lenses [LAL] continue to gain traction in the $6 billion-plus cataract surgical market. In their Q3 earnings report, RxSight announced that 24,554 LALs were sold in Q3, repr...

7 months ago - Seeking Alpha

RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Oliver Moravcevic - Vice President, Investor Relations Ron Kurtz - President, Chief Execu...

8 months ago - Seeking Alpha

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

9 months ago - GlobeNewsWire

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

11 months ago - GlobeNewsWire

Investing In The Future Of Cataract Surgery: The RxSight Advantage

RxSight, Inc. is transforming cataract surgery with the Light Adjustable Lens system, offering postoperative customization for superior vision outcomes. The global cataract devices market is rapidly e...

11 months ago - Seeking Alpha

RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Ron Kurtz - President, Chief Executive Officer Shelley Thunen - Assistant Secretary, Chief ...

1 year ago - Seeking Alpha

RxSight, Inc. Reports Second Quarter 2024 Financial Results

ALISO VIEJO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

1 year ago - GlobeNewsWire

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

1 year ago - GlobeNewsWire